Cargando…

S2.3 Therapeutic approaches in the late onset form of GSD II

Detalles Bibliográficos
Autores principales:	Musumeci, Olimpia, Barca, Emanuele, Toscano, Antonio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Pacini Editore SpA 2011
Materias:	Session 2. Management of Pompe Disease
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3298104/

Ejemplares similares

S2.2 Enzyme replacement therapy in the infantile-onset Pompe disease
por: Parenti, Giancarlo, et al.
Publicado: (2011)

S2.1 Enzyme replacement therapy (ERT) in Glycogen Storage Disease Type II: the first treatment developed
por: Angelini, Corrado, et al.
Publicado: (2011)

S2.5 The nutritional approach to Pompe disease
por: Esposito, Katia, et al.
Publicado: (2011)

S2.4 The role of rehabilitation in the management of metabolic myopathies
por: Riccio, Ilaria, et al.
Publicado: (2011)

Quantitative muscle MRI and functional measures in a cohort of late onset GSD II patients
por: Musumeci, O, et al.
Publicado: (2013)

Clinical, morphological and genetic features of a cohort of late onset GSD II patients: typical and atypical presentations
por: Barca, E, et al.
Publicado: (2013)

S3.1 Are there ERT defined guidelines for Pompe disease?
por: Toscano, Antonio, et al.
Publicado: (2011)

S1.3 Adult-onset Pompe disease
por: Di Iorio, Giuseppe, et al.
Publicado: (2011)

S1.5 Role of the pulmonologist in the late-onset Pompe disease
por: Fiorentino, Giuseppe, et al.
Publicado: (2011)

O-3 Clinical features and outcome measures during 1 year enzyme replacement therapy in late onset GSD II patients
por: Angelini, C., et al.
Publicado: (2011)

S1.1 Introductory notes to Pompe disease and aims of the Meeting
por: Sampaolo, Simone, et al.
Publicado: (2011)

S1.2 The pediatrician and the early onset Pompe disease
por: Fecarotta, Simona, et al.
Publicado: (2011)

Early is better? A new algorithm for early diagnosis in Late Onset Pompe Disease (LOPD)
por: TOSCANO, ANTONIO, et al.
Publicado: (2013)

S1.6 Dry blood spot: a new method for early diagnosis
por: Donati, M.A.
Publicado: (2011)

S1.4 Cardiovascular involvement in Pompe disease
por: Limongelli, Giuseppe, et al.
Publicado: (2011)

Late-onset Bartter syndrome type II
por: Gollasch, Benjamin, et al.
Publicado: (2017)

Diagnostic Challenges in Late Onset Multiple Acyl-CoA Dehydrogenase Deficiency: Clinical, Morphological, and Genetic Aspects
por: Lupica, Antonino, et al.
Publicado: (2022)

Vacuolated PAS-Positive Lymphocytes on Blood Smear: An Easy Screening Tool and a Possible Biomarker for Monitoring Therapeutic Responses in Late Onset Pompe Disease (LOPD)
por: Parisi, Daniela, et al.
Publicado: (2018)

SorGSD: a sorghum genome SNP database
por: Luo, Hong, et al.
Publicado: (2016)

DoGSD: the dog and wolf genome SNP database
por: Bai, Bing, et al.
Publicado: (2014)

Clinical and genetic spectrum of GSD type 6 in Korea
por: Hahn, Jong Woo, et al.
Publicado: (2023)

Long COVID and rheumatology: Clinical, diagnostic, and therapeutic implications
por: Calabrese, Cassandra, et al.
Publicado: (2022)

Sextuors op. 23 no 1, 2 & 5
por: Boccherini, Luigi, 1743-1805
Publicado: (1994)

Erratum to: SorGSD: a sorghum genome SNP database
por: Luo, Hong, et al.
Publicado: (2016)

Are the Bacteria and Their Metabolites Contributing for Gut Inflammation on GSD-Ia Patients?
por: Colonetti, Karina, et al.
Publicado: (2022)

Monday, May 12, 2008: Poster Session 2
Publicado: (2008)

Sunday, June 27, 2010: Poster Session 2
Publicado: (2010)

65: SEVERE MALARIA IN CANADA: 2018–2021 UPDATE FROM THE CANADIAN MALARIA NETWORK
por: Poenaru, S., et al.
Publicado: (2022)

54: THE IMPACT OF THE CORONAVIRUS DISEASE PANDEMIC ON RESPIRATORY-RELATED INFECTIONS IN JAPAN
por: Kitagawa, D., et al.
Publicado: (2022)

63: A MICROBIOLOGICAL RETROSPECTIVE REVIEW OF BLOOD STREAM INFECTIONS IN COVID-19 PATIENTS FROM A TERTIARY CARE CENTER IN LEBANON
por: Nahhal, S., et al.
Publicado: (2022)

69: COMPARING THE OUTCOMES OF GIVING TOCILIZUMAB THEN HEMOPERFUSION, HEMOPERFUSION THEN TOCILIZUMAB, AND NO INTERVENTION IN CRITICAL SARS-COV-2 PNEUMONIA PATIENTS IN MAKATI MEDICAL CENTER
por: Macatangay, M.V.R., et al.
Publicado: (2022)

64: BACTERIAL RESPIRATORY INFECTIONS IN PATIENTS WITH COVID-19: A RETROSPECTIVE STUDY FROM A TERTIARY CARE CENTER IN LEBANON
por: Shmoury, A., et al.
Publicado: (2022)

61: SECONDARY INFECTION DURING THE THIRDWAVE OF COVID-19 IN A HOSPITAL IN KATHMANDU
por: Baishnab, S.K. Mishra
Publicado: (2022)

58: SARS-COV-2 ANTIBODY CHARACTERISTICS OF SALIVA FROM VACCINATED INDIVIDUALS
por: Ota, K., et al.
Publicado: (2022)

Finding balance between mature and immature neutrophils: The effects of empagliflozin in GSD‐Ib
por: Guerra, Fabiola, et al.
Publicado: (2023)

Statins Neuromuscular Adverse Effects
por: Attardo, Silvia, et al.
Publicado: (2022)

Case 5/2015 Late Outcome of Corrected Aortopulmonary Window in A 23-Year-Old Female Patient Who Underwent Surgery in Childhood
por: Atik, Edmar
Publicado: (2015)

Case Report: Thymidine Kinase 2 (TK2) Deficiency: A Novel Mutation Associated With Childhood-Onset Mitochondrial Myopathy and Atypical Progression
por: Manini, Arianna, et al.
Publicado: (2022)

SorGSD: updating and expanding the sorghum genome science database with new contents and tools
por: Liu, Yuanming, et al.
Publicado: (2021)

A novel approach to characterize phenotypic variation in GSD IV: Reconceptualizing the clinical continuum
por: Kiely, Bridget T., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ljgka28mfa4nf5qm9adbh11nt0